Compare TSEM & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSEM | BAX |
|---|---|---|
| Founded | 1993 | 1931 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 10.2B |
| IPO Year | 1996 | 1994 |
| Metric | TSEM | BAX |
|---|---|---|
| Price | $203.68 | $18.52 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 9 |
| Target Price | ★ $161.75 | $21.00 |
| AVG Volume (30 Days) | 2.7M | ★ 6.1M |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $19.21 | $1.96 |
| Revenue Next Year | $26.62 | $2.22 |
| P/E Ratio | $66.16 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $34.73 | $15.73 |
| 52 Week High | $228.73 | $32.68 |
| Indicator | TSEM | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 57.92 |
| Support Level | $111.97 | $17.69 |
| Resistance Level | $228.73 | $18.97 |
| Average True Range (ATR) | 13.51 | 0.62 |
| MACD | -3.62 | 0.17 |
| Stochastic Oscillator | 26.10 | 73.74 |
Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs), based on the design specifications of customers. The company's line of integrated circuits is incorporated into a range of products and markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.